Association between anti-TNF-α therapy and all-cause mortality-Reference-Cited by-同舟云学术

Association between anti-TNF-α therapy and all-cause mortality

Published:2012-10-15 Issue:12 Volume:21 Page:1311-1320
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Herrinton Lisa J.¹,Liu Liyan¹,Chen Lang²,Harrold Leslie R.³,Raebel Marsha A.⁴,Curtis Jeffrey R.²,Griffin Marie R.⁵,Solomon Daniel H.⁶,Saag Kenneth G.²,Lewis James D.⁷

Affiliation:

1. Division of Research; Kaiser Permanente; Oakland; CA; USA

2. UAB Center for Education and Research and Therapeutics of Musculoskeletal Disorders; University of Alabama at Birmingham; Birmingham; AL; USA

3. Department of Rheumatology, Department of Medicine, University of Massachusetts Medical School; Meyers Primary Care Institute and Fallon Clinic; Worcester; MA; USA

4. Institute for Health Research; Kaiser Permanente Colorado; Denver; CO; USA

5. Departments of Preventive Medicine and Medicine, Vanderbilt University School of Medicine and the Mid-South Geriatric Research Education and Clinical Center; Veterans Administration Tennessee Valley Health Care System; Nashville; TN; USA

6. Division of Rheumatology, Division of Pharmacoepidemiology; Brigham and Women's Hospital; Boston; MA; USA

7. Department of Medicine, Department of Biostatistics and Epidemiology; University of Pennsylvania; USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference24 articles.

1. Initiation of biologic DMARDs and the risk of hospitalization for infection in patients with autoimmune disease;Grijalva;JAMA,2011

2. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275-85. Review. Erratum in;Bongartz;JAMA,2006

3. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study;Naranjo;Arthritis Res Ther,2008

4. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis;Jacobsson;J Rheumatol,2005

5. All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists;Carmona;Ann Rheum Dis,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between inflammatory bowel disease and all-cause and cause-specific mortality in the UK Biobank;Annals of Epidemiology;2023-12

2. Can we change the natural course of inflammatory bowel disease?;Therapeutic Advances in Gastroenterology;2023-01

3. Assessment of the effect of DMARD use on the mortality of patients with rheumatoid arthritis;Ulusal Romatoloji Dergisi;2022-08-29

4. Real world evidence of the association between medication and life expectancy in elderly inflammatory bowel disease: a population-based cohort study;BMC Gastroenterology;2022-01-04

5. Features of inflammatory rheumatic diseases treatment in older people;Russian Journal of Geriatric Medicine;2021-10-15